Development of a multi-antigenic SARS-CoV-2 vaccine candidate using a synthetic poxvirus platform

被引：66

作者：

Chiuppesi, Flavia ^{[1
,2
]}

Salazar, Marcela d'Alincourt ^{[1
,2
]}

Contreras, Heidi ^{[1
,2
]}

Nguyen, Vu H. ^{[1
,2
]}

Martinez, Joy ^{[1
,2
]}

Park, Yoonsuh ^{[1
,2
]}

Nguyen, Jenny ^{[1
,2
]}

Kha, Mindy ^{[1
,2
]}

Iniguez, Angelina ^{[1
,2
]}

Zhou, Qiao ^{[1
,2
]}

Kaltcheva, Teodora ^{[1
,2
]}

Levytskyy, Roman ^{[1
,2
]}

Ebelt, Nancy D. ^{[3
]}

Kang, Tae Hyuk ^{[4
]}

Wu, Xiwei ^{[4
]}

Rogers, Thomas F. ^{[5
,6
]}

Manuel, Edwin R. ^{[3
]}

Shostak, Yuriy ^{[7
]}

Diamond, Don J. ^{[1
,2
]}

Wussow, Felix ^{[1
,2
]}

机构：

[1] City Hope Natl Med Ctr, Dept Hematol, Duarte, CA 91010 USA

[2] City Hope Natl Med Ctr, Transplant Ctr, Duarte, CA 91010 USA

[3] City Hope Natl Med Ctr, Dept Immunooncol, Beckman Res Inst, Duarte, CA 91010 USA

[4] City Hope Natl Med Ctr, Integrat Genom Core, Beckman Res Inst, Duarte, CA 91010 USA

[5] Univ Calif San Diego, Sch Med, Div Infect Dis & Global Publ Hlth, 9500 Gilman Dr, La Jolla, CA 92093 USA

[6] Scripps Res, Dept Immunol & Microbiol, 10550N Torrey Pines Rd, La Jolla, CA 92037 USA

[7] City Hope Natl Med Ctr, Res Business Dev, Duarte, CA 91010 USA

来源：

NATURE COMMUNICATIONS | 2020年 / 11卷 / 01期

基金：

美国国家卫生研究院;

关键词：

VIRUS ANKARA; MOLECULAR-CLONING; GENOMIC SEQUENCE; STRAIN; DNA;

D O I：

10.1038/s41467-020-19819-1

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

Modified Vaccinia Ankara (MVA) is a highly attenuated poxvirus vector that is widely used to develop vaccines for infectious diseases and cancer. We demonstrate the construction of a vaccine platform based on a unique three-plasmid system to efficiently generate recombinant MVA vectors from chemically synthesized DNA. In response to the ongoing global pandemic caused by SARS coronavirus-2 (SARS-CoV-2), we use this vaccine platform to rapidly produce fully synthetic MVA (sMVA) vectors co-expressing SARS-CoV-2 spike and nucleocapsid antigens, two immunodominant antigens implicated in protective immunity. We show that mice immunized with these sMVA vectors develop robust SARS-CoV-2 antigen-specific humoral and cellular immune responses, including potent neutralizing antibodies. These results demonstrate the potential of a vaccine platform based on synthetic DNA to efficiently generate recombinant MVA vectors and to rapidly develop a multi-antigenic poxvirus-based SARS-CoV-2 vaccine candidate.

引用

页数：16

共 57 条

[1] Poxvirus Vectored Cytomegalovirus Vaccine to Prevent Cytomegalovirus Viremia in Transplant Recipients A Phase 2, Randomized Clinical Trial
Aldoss, Ibrahim
La Rosa, Corinna
Baden, Lindsey R.
Longmate, Jeffrey
Ariza-Heredia, Ella J.
Rida, Wasima N.
Lingaraju, Chetan Raj
Zhou, Qiao
Martinez, Joy
Kaltcheva, Teodora
Dagis, Andy
Hardwick, Nicola
Issa, Nicolas C.
Farol, Len
Nademanee, Auayporn
Al Malki, Monzr M.
Forman, Stephen
Nakamura, Ryotaro
Diamond, Don J.
[J]. ANNALS OF INTERNAL MEDICINE, 2020, 172 (05) : 306 - +
[2] The complete genomic sequence of the modified vaccinia Ankara strain: Comparison with other orthopoxviruses
Antoine, G
Scheiflinger, F
Dorner, F
Falkner, FG
[J]. VIROLOGY, 1998, 244 (02) : 365 - 396
[3] STRUCTURE AND REPLICATION OF VACCINIA VIRUS TELOMERES
BAROUDY, BM
VENKATESAN, S
MOSS, B
[J]. COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY, 1982, 47 : 723 - 729
[4] Birnboim H. C., 1979, NUCLEIC ACIDS RES, V7, P1513
[5] Host range and cytopathogenicity of the highly attenuated MVA strain of vaccinia virus: Propagation and generation of recombinant viruses in a nonhuman mammalian cell line
Carroll, MW
Moss, B
[J]. VIROLOGY, 1997, 238 (02) : 198 - 211
[6] Multiantigenic Modified Vaccinia Virus Ankara Vaccine Vectors To Elicit Potent Humoral and Cellular Immune Reponses against Human Cytomegalovirus in Mice
Chiuppesi, Flavia
Nguyen, Jenny
Park, Soojin
Contreras, Heidi
Kha, Mindy
Meng, Zhuo
Kaltcheva, Teodora
Iniguez, Angelina
Martinez, Joy
La Rosa, Corinna
Wussow, Felix
Diamond, Don J.
[J]. JOURNAL OF VIROLOGY, 2018, 92 (19)
[7] Recombinant MVA vaccines: dispelling the myths
Cottingham, Matthew G.
Carroll, Miles W.
[J]. VACCINE, 2013, 31 (39) : 4247 - 4251
[8] Recombination-Mediated Genetic Engineering of a Bacterial Artificial Chromosome Clone of Modified Vaccinia virus Ankara (MVA)
Cottingham, Matthew G.
Andersen, Rikke F.
Spencer, Alexandra J.
Saurya, Saroj
Furze, Julie
Hill, Adrian V. S.
Gilbert, Sarah C.
[J]. PLOS ONE, 2008, 3 (02):
[9] Protocol and Reagents for Pseudotyping Lentiviral Particles with SARS-CoV-2 Spike Protein for Neutralization Assays
Crawford, Katharine H. D.
Eguia, Rachel
Dingens, Adam S.
Loes, Andrea N.
Malone, Keara D.
Wolf, Caitlin R.
Chu, Helen Y.
Tortorici, M. Alejandra
Veesler, David
Murphy, Michael
Pettie, Deleah
King, Neil P.
Balazs, Alejandro B.
Bloom, Jesse D.
[J]. VIRUSES-BASEL, 2020, 12 (05):
[10] Impact of immune enhancement on Covid-19 polyclonal hyperimmune globulin therapy and vaccine development
de Alwis, Ruklanthi
Chen, Shiwei
Gan, Esther S.
Ooi, Eng Eong
[J]. EBIOMEDICINE, 2020, 55

← 1 2 3 4 5 6 →